Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
1.380
+0.030 (2.22%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $41.53 million as of April 1, 2025. Its market cap has decreased by -5.19% in one year.
Market Cap
41.53M
Enterprise Value
36.43M
1-Year Change
-5.19%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $41.53M, a decrease of -56.20%. That is a compound annual growth rate of -12.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 40.60M | -21.62% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |